Kalvista Pharmaceuticals Inc (KALV): Congress and insider trades
Who in Congress and inside the company traded KALV, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Kalvista Pharmaceuticals Inc (KALV) is a listed stock on NASDAQ.
- Insiders filed 0 open market buys worth $0 and 16 sells worth $5.7M, the latest filed 2026-05-29 (29 May 2026).
- Data as of 2026-09-29 (29 September 2026).
Insider trades in KALV
as of 2026-05-29| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 29 May 2026 | Yea Christopher | sell | 33,800 | $26.78 | $905K | n/a |
| 27 May 2026 | Sweeny Nicole | sell | 1,489 | $26.78 | $39.9K | n/a |
| 27 May 2026 | Yea Christopher | sell | 1,966 | $26.78 | $52.6K | n/a |
| 27 May 2026 | Audhya Paul K. | sell | 2,239 | $26.78 | $60.0K | n/a |
| 26 May 2026 | Piekos Brian | sell | 1,489 | $26.78 | $39.9K | n/a |
| 26 May 2026 | Sweeny Nicole | sell | 1,861 | $26.78 | $49.8K | n/a |
| 26 May 2026 | Yea Christopher | sell | 2,358 | $26.78 | $63.2K | n/a |
| 26 May 2026 | Palleiko Benjamin L | sell | 10,926 | $26.78 | $293K | n/a |
| 26 May 2026 | Audhya Paul K. | sell | 2,685 | $26.78 | $71.9K | n/a |
| 20 Apr 2026 | Palleiko Benjamin L | sell | 9,550 | $20.22 | $193K | n/a |
| 20 Apr 2026 | Audhya Paul K. | sell | 2,686 | $20.22 | $54.3K | n/a |
| 20 Apr 2026 | Piekos Brian | sell | 1,862 | $20.22 | $37.6K | n/a |
| 20 Apr 2026 | Sweeny Nicole | sell | 1,862 | $20.22 | $37.6K | n/a |
| 27 Mar 2026 | Venrock Healthcare Capital Par | sell | 39,986 | $18.28 | $731K | n/a |
| 27 Mar 2026 | Venrock Healthcare Capital Par | sell | 174,645 | $16.95 | $3.0M | n/a |
| 10 Mar 2026 | Palleiko Benjamin L | sell | 6,693 | $16.08 | $108K | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought KALV?
0 Congress buys by 0 members and 0 insider buys are on file. The tables on this page list every one.
Did buying KALV after a disclosure beat the market?
No disclosed buy of this stock has matured 90 days yet. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.